FIELD: medicine.
SUBSTANCE: declared invention refers to medicine and represents a method for prevention of ischemic and reperfusion injuries of the hippocampus neurons in the postresuscitative period, involving the use of lithium salts, characterized by that as an agent for preventing ischemic and reperfusion injuries of the hippocampus neonones in the postresuscitative period, 4.2 % lithium chloride solution is used in dose of 40 mg/kg by single intravenous introduction immediately after recovery of spontaneous cardiac activity and subsequent introduction on 1st, 2nd and 3rd post-intensive day.
EFFECT: use of the declared invention enables to neutralize consequences of both neuron ischemia and pathogenic extracerebral factors occurring in generalized reperfusion conditions.
1 cl, 3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF BRAIN ISCHEMIA | 2017 |
|
RU2642961C1 |
| METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
| ESTROGEN COMPONENTS FOR APPLICATION IN NEUROLOGICAL DISORDERS TREATMENT | 2013 |
|
RU2627846C2 |
| METHOD OF REHABILITATION AFTER HYPOXIA CAUSING BRAIN DYSFUNCTION IN LABORATORY ANIMAL MODELS | 2010 |
|
RU2437164C1 |
| NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
| MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
| INTERLEUKIN-10, USING IT AND BASED COMPOSITION FOR TREATING BRAIN NEURODEGENERATIVE PROCESSES | 2012 |
|
RU2538613C2 |
| CHINESE DRUG COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES OR DEMENTIA AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2674264C1 |
| AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
| AGENT POSSESSING CARDIO-, NEPHRO-, ENDOTHELIAL-, MICROANGIO-, MACROANGIO- AND ENCEPHALOPROTECTIVE PROPERTIES | 2018 |
|
RU2700791C1 |
